Sophiris Bio Company Profile (NASDAQ:SPHS)

Analyst Ratings

Consensus Ratings for Sophiris Bio (NASDAQ:SPHS) (?)
Ratings Breakdown: 2 Buy Rating(s)
Consensus Rating:Buy (Score: 3.00)
Consensus Price Target: $4.50 (2.74% upside)

Analysts' Ratings History for Sophiris Bio (NASDAQ:SPHS)
Show:
DateFirmActionRatingPrice TargetActions
6/10/2016Echelon Wealth PartnersReiterated RatingBuy$5.00View Rating Details  Tweet This Rating  Share This Rating on StockTwits
6/10/2016Maxim GroupReiterated RatingBuy$4.00View Rating Details  Tweet This Rating  Share This Rating on StockTwits
12/18/2014Stifel NicolausDowngradeBuy -> Hold$7.00View Rating Details  Tweet This Rating  Share This Rating on StockTwits
10/16/2014Leerink SwannInitiated CoverageOutperform$5.00View Rating Details  Tweet This Rating  Share This Rating on StockTwits
(Data available from 7/23/2014 forward)

Earnings

Earnings History for Sophiris Bio (NASDAQ:SPHS)
DateQuarterConsensus EstimateActual EPSRevenue EstimateActual RevenueRelease LinkConference CallActions
8/5/2016        
5/16/2016Q1($0.19)($0.13)ViewN/AView Earnings Details  Tweet This Announcement  Share This Announcement on StockTwits
3/23/2016Q4($0.15)ViewN/AView Earnings Details  Tweet This Announcement  Share This Announcement on StockTwits
11/16/2015Q3($0.22)ViewN/AView Earnings Details  Tweet This Announcement  Share This Announcement on StockTwits
5/13/2015($0.30)($0.26)ViewN/AView Earnings Details  Tweet This Announcement  Share This Announcement on StockTwits
3/10/2015($0.47)($0.31)ViewN/AView Earnings Details  Tweet This Announcement  Share This Announcement on StockTwits
11/13/2014($0.54)($0.49)ViewN/AView Earnings Details  Tweet This Announcement  Share This Announcement on StockTwits
5/13/2014Q114($0.50)($0.52)ViewN/AView Earnings Details  Tweet This Announcement  Share This Announcement on StockTwits
(Data available from 1/1/2011 forward)

Estimates

Earnings Estimates for Sophiris Bio (NASDAQ:SPHS)
No earnings estimates for this company have been tracked by MarketBeat.com

Dividends

Dividend History for Sophiris Bio (NASDAQ:SPHS)
No dividend announcements for this company have been tracked by MarketBeat.com

Insider Trades

Insider Trading History for Sophiris Bio (NASDAQ:SPHS)
Transaction DateInsider NameTitleBuy/SellNumber of SharesAverage Share PriceTotal TransactionActions
12/15/2014Boxer Capital, LlcMajor ShareholderSell881,479$0.61$537,702.19View SEC Filing  Tweet This Trade  Share This Trade on StockTwits
11/14/2014Randall E WoodsInsiderBuy3,000$2.43$7,290.00View SEC Filing  Tweet This Trade  Share This Trade on StockTwits
9/19/2014Gerald T ProehlDirectorBuy10,000$3.16$31,600.00View SEC Filing  Tweet This Trade  Share This Trade on StockTwits
7/10/2014Randall E WoodsInsiderBuy1,000$2.65$2,650.00View SEC Filing  Tweet This Trade  Share This Trade on StockTwits
7/9/2014Randall E WoodsInsiderBuy1,000$2.66$2,660.00View SEC Filing  Tweet This Trade  Share This Trade on StockTwits
6/6/2014James L HeppellDirectorSell19,231$2.59$49,808.29View SEC Filing  Tweet This Trade  Share This Trade on StockTwits
8/22/2013Randall E WoodsCEOBuy2,500$4.50$11,250.00View SEC Filing  Tweet This Trade  Share This Trade on StockTwits
8/20/2013Peter T SloverCFOBuy4,680$4.25$19,890.00View SEC Filing  Tweet This Trade  Share This Trade on StockTwits
8/19/2013Randall E WoodsCEOBuy10,000$4.29$42,900.00View SEC Filing  Tweet This Trade  Share This Trade on StockTwits
8/16/2013Boxer Capital, LlcMajor ShareholderBuy1,600,000$5.00$8,000,000.00View SEC Filing  Tweet This Trade  Share This Trade on StockTwits
(Data available from 1/1/2013 forward)

Headlines

Latest Headlines for Sophiris Bio (NASDAQ:SPHS)
DateHeadline
07/22/16 06:19 PMTrading Examination: Performance check on Sophiris Bio, Inc. (NASDAQ:SPHS) - TGP
07/22/16 06:19 PMIncreased Volatility Noted on Shares of: Sophiris Bio, Inc. (NASDAQ:SPHS) - Engelwood Daily
07/22/16 06:19 PMInvestor Attention Turning to Shares of Sophiris Bio, Inc. (NASDAQ:SPHS) - Engelwood Daily
07/22/16 06:19 PMTalking Trading: Active Stock Rundown for Sophiris Bio, Inc. (NASDAQ:SPHS) - Press Telegraph
07/22/16 06:19 PMShares Reaching Higher Ground in Session: Sophiris Bio, Inc. (NASDAQ:SPHS) - TGP
07/22/16 06:19 PMTwo Stocks within Analysts Review: Sophiris Bio, Inc. (NASDAQ:SPHS) , Tenet Healthcare Corporation (NYSE:THC) - Street Updates
07/21/16 06:52 PMChecking in on Stock Volatility for: Sophiris Bio, Inc. (NASDAQ:SPHS) - Engelwood Daily
07/21/16 06:52 PMSophiris Bio, Inc. (NASDAQ:SPHS): Share Synopsis and Trading Review - Press Telegraph
07/21/16 06:52 PMMarket Minute - Focus on Sophiris Bio, Inc. (NASDAQ:SPHS) Stock - TGP
07/20/16 07:29 PMHeightened Volatility Spotted on Shares of: Sophiris Bio, Inc. (NASDAQ:SPHS) - Engelwood Daily
07/19/16 06:43 PMStock Ticking Higher in Trading: Sophiris Bio, Inc. (NASDAQ:SPHS) - TGP
07/19/16 06:43 PMConsensus Analyst Target Price Check for Sophiris Bio, Inc. (NASDAQ:SPHS) - Press Telegraph
07/19/16 06:42 PMPerformance Overview of the company: Sophiris Bio, Inc. (NASDAQ:SPHS) - News Oracle
07/19/16 07:31 AMInvestor Watch: Volatility Recap on Shares of: Sophiris Bio, Inc. (NASDAQ:SPHS) - Engelwood Daily
07/19/16 07:31 AMStocks Buzz: Brocade Communications Systems, Inc. (BRCD) Sophiris Bio, Inc. (SPHS) TD Ameritrade Holding ... - iStreetWire
07/19/16 07:31 AMSophiris Bio Inc (NASDAQ:SPHS)'s Company Shares Increased 27.27% After Low Volatility - Consumer Eagle
07/18/16 11:02 AMTracking Trading Performance for: Sophiris Bio, Inc. (NASDAQ:SPHS) - TGP
07/17/16 05:53 PMTrading Focus on Shares of: Sophiris Bio, Inc. (NASDAQ:SPHS) - TGP
07/17/16 10:34 AMStrong Sell Calls For Sophiris Bio, Inc. (NASDAQ:SPHS) At 0 - Investor Newswire
07/15/16 11:45 AMInstitutional Investor's Pro-Sophiris Bio Inc (NASDAQ:SPHS) Sentiment In Q1 2016 - Press Telegraph
07/14/16 06:47 PMShare Volatility Watch for: Sophiris Bio, Inc. (NASDAQ:SPHS) - Engelwood Daily
07/14/16 06:47 PMSophiris Bio, Inc. (NASDAQ:SPHS): Stock Review and Performance Update - Press Telegraph
07/14/16 06:47 PMSophiris Bio, Inc. (NASDAQ:SPHS) Analyst Average Stock Rating - Engelwood Daily
07/14/16 06:47 PMBroker Outlook For Sophiris Bio, Inc. (SPHS) - Fiscal Standard
07/13/16 09:26 AMNew Broker Ratings For Sophiris Bio, Inc. (SPHS) - FTSE News
07/13/16 09:26 AMCompany Sentiment Score Update:Sophiris Bio, Inc. (NASDAQ:SPHS) - Press Telegraph
07/12/16 06:47 PMEquity Review - Shares in Focus: Sophiris Bio, Inc. (NASDAQ:SPHS) - Telanagana Press
07/12/16 06:47 PMSophiris Bio, Inc. (NASDAQ:SPHS) Company Stock Rating in Focus - Engelwood Daily
07/12/16 06:47 PMTrending Stock Performance Check: Sophiris Bio, Inc. (NASDAQ:SPHS) - Press Telegraph
07/11/16 06:27 PMTrading Review - Company in Focus: Sophiris Bio, Inc. (NASDAQ:SPHS) - Telanagana Press
07/11/16 06:27 PMCompany Shares of Sophiris Bio (NASDAQ:SPHS) Rally 12.44% - TheFounders Daily
07/11/16 06:27 PMStock Volatility Focus for: Sophiris Bio, Inc. (NASDAQ:SPHS) - Engelwood Daily
07/11/16 06:27 PMImpact Score and Stock Sentiment Outlook :Sophiris Bio, Inc. (NASDAQ:SPHS) - Press Telegraph
07/09/16 05:49 PMIs $4 Within Reach For Sophiris Bio, Inc. (NASDAQ:SPHS)? - Investor Newswire
07/08/16 06:29 PMIncreased Volatility on Shares of: Sophiris Bio, Inc. (NASDAQ:SPHS) - Engelwood Daily
07/08/16 06:29 PMSophiris Bio, Inc. (NASDAQ:SPHS) - Focus Company Stock in Review - Engelwood Daily
07/08/16 06:29 PMNews Sentiment and Impact Score Review for :Sophiris Bio, Inc. (NASDAQ:SPHS) - Press Telegraph
07/08/16 06:29 PMSophiris Bio, Inc. (SPHS) Current Analyst Ratings - Fiscal Standard
07/03/16 05:45 PMSophiris Bio, Inc. (NASDAQ:SPHS) Expected to Reach Highs Of $4 - Investor Newswire
07/03/16 05:45 PMSophiris Bio, Inc. (NASDAQ:SPHS) Impact Score and Stock Sentiment Recap - Press Telegraph
07/02/16 09:07 AMTracking Stock Volatility for: Sophiris Bio, Inc. (NASDAQ:SPHS) - Engelwood Daily
06/30/16 09:16 AMWatching Stock Volatility for: Sophiris Bio, Inc. (NASDAQ:SPHS) - Engelwood Daily
06/27/16 06:26 PMWatching Stock Sentiment for:Sophiris Bio, Inc. (NASDAQ:SPHS) - Press Telegraph
06/27/16 06:26 PMSophiris Bio, Inc. (NASDAQ:SPHS) Recent Performance and Company Stock Review - Engelwood Daily
06/27/16 10:32 AMNext Weeks Broker Price Targets For Sophiris Bio, Inc. (SPHS) - Fiscal Standard
06/25/16 05:55 PMSophiris Bio, Inc. (NASDAQ:SPHS): Update on Stock Performance - Press Telegraph
06/25/16 05:55 PMStrong Sell Calls Recommendations For Sophiris Bio, Inc. (NASDAQ:SPHS) At 0 - Investor Newswire
06/24/16 09:05 AMBrokers Issue Average Price Target Of 5.50 On Sophiris Bio, Inc. (SPHS) - Fiscal Standard
06/24/16 09:05 AMImpact Score Outlook on:Sophiris Bio, Inc. (NASDAQ:SPHS) - Press Telegraph
06/23/16 07:13 PMStock Watch for: Sophiris Bio, Inc. (NASDAQ:SPHS) - Press Telegraph

Social

About Sophiris Bio

Sophiris Bio logoSophiris Bio, Inc., formerly Protox Therapeutics Inc., is a Canada-based biopharmaceutical company focused on the research, development and commercialization of products for the treatment of urological diseases. The Company has operations based in San Diego developing a treatment for benign prostatic hyperplasia (benign prostatic hyperplasia (BPH) or enlarged prostate). The Company has partnered with Kissei Pharmaceuticals for the development and commercialization of PRX302 in Japan. Sophiris Bio, Inc. is advancing a pipeline of receptor targeted fusion proteins based on three complementary technology platforms: PORxin, INxin and HUMxin. It focuses on diseases of the prostate via its PORxin platform candidate, PRX302, which has completed three clinical trials for the treatment of BPH, as well as two clinical trials for the treatment of localized recurrent prostate cancer.

Industry, Sector and Symbol:
  • Sector: Medical
  • Industry: Drugs - Generic
  • Sub-Industry: N/A
  • Exchange: NASDAQ
  • Symbol: SPHS
  • CUSIP:
Key Metrics:
  • Previous Close: $4.38
  • 50 Day Moving Average: $2.16
  • 200 Day Moving Average: $1.69
  • P/E Ratio: N/A
  • P/E Growth: 0.00
  • Market Cap: $91.17M
  • Beta: 0.36
Additional Links:
Sophiris Bio (NASDAQ:SPHS) Chart for Saturday, July, 23, 2016